A SYSTEMATIC REVIEW OF COMPARATIVE EFFECTIVENESS MODELS AND ECONOMIC EVALUATIONS FOR CANCER RISK MANAGEMENT STRATEGIES IN BRCA1/2 MUTATION CARRIERS

被引：0
|
作者：
Petelin, Lara [1 ,2 ,3 ]
Trainer, Alison [1 ,2 ,3 ]
Liew, Danny [4 ,5 ]
James, Paul [1 ,2 ,3 ]
Mitchell, Gillian [1 ,2 ,3 ]
机构：
[1] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia
[2] Peter MacCallum Canc Ctr, Familial Canc Ctr, Melbourne, Vic, Australia
[3] Royal Melbourne Hosp, Melbourne, Vic, Australia
[4] Monash Hlth, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia
[5] Univ Melbourne, Dept Med, Melbourne, Vic, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
329
引用
收藏
页码：155 / 156
页数：2
相关论文
共 50 条
  • [1] Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review
    Petelin, Lara
    Trainer, Alison H.
    Mitchell, Gillian
    Liew, Danny
    James, Paul A.
    GENETICS IN MEDICINE, 2018, 20 (10) : 1145 - 1156
  • [2] Effectiveness of preventive interventions in BRCA1/2 gene mutation carriers:: A systematic review
    Bermejo-Perez, M. J.
    Marquez-Calderon, S.
    Llanos-Mendez, A.
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (02) : 225 - 231
  • [3] Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
    Lisa Krassuski
    Vera Vennedey
    Stephanie Stock
    Sibylle Kautz-Freimuth
    BMC Medical Informatics and Decision Making, 19
  • [4] Effectiveness of decision aids for female BRCA1 and BRCA2 mutation carriers: a systematic review
    Krassuski, Lisa
    Vennedey, Vera
    Stock, Stephanie
    Kautz-Freimuth, Sibylle
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2019, 19 (1)
  • [5] Risk Management for BRCA1/BRCA2 Mutation Carriers Without and With Breast Cancer
    Mainor, C. B.
    Isaacs, C.
    CURRENT BREAST CANCER REPORTS, 2020, 12 (02) : 66 - 74
  • [6] Risk Management for BRCA1/BRCA2 Mutation Carriers Without and With Breast Cancer
    C. B. Mainor
    C. Isaacs
    Current Breast Cancer Reports, 2020, 12 : 66 - 74
  • [7] Modifiers of Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: Systematic Review and Meta-Analysis
    Friebel, Tara M.
    Domchek, Susan M.
    Rebbeck, Timothy R.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2014, 106 (06):
  • [8] Cardiovascular risk of BRCA1/2 mutation carriers: A review
    van Westerop, L. L. M.
    Jong, M. Arts-de
    Hoogerbrugge, N.
    de Hullu, J. A.
    Maas, A. H. E. M.
    MATURITAS, 2016, 91 : 135 - 139
  • [9] Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers
    Latosinsky, Steve
    Cheifetz, Rona E.
    Wilke, Lee G.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2011, 213 (03) : 447 - 450
  • [10] Survival Analysis of Cancer Risk Reduction Strategies for BRCA1/2 Mutation Carriers
    Kurian, Allison W.
    Sigal, Bronislava M.
    Plevritis, Sylvia K.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) : 222 - 231
12345